Literature DB >> 8391934

Betaglycan presents ligand to the TGF beta signaling receptor.

F López-Casillas1, J L Wrana, J Massagué.   

Abstract

Transforming growth factor beta (TGF beta) signals through a heteromeric protein kinase receptor that has a limited ability to bind ligand. This limitation is overcome by the action of betaglycan (TGF beta type III receptor), a separate TGF beta-binding membrane protein of previously unknown function. Betaglycan presents TGF beta directly to the kinase subunit of the signaling receptor, forming a high affinity ternary complex. Membrane betaglycan increases TGF beta binding to the signaling receptor, enhances cell responsiveness to TGF beta, and eliminates marked biological differences between TGF beta isoforms. Thus, betaglycan is a direct regulator of TGF beta access to the signaling receptors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8391934     DOI: 10.1016/0092-8674(93)90368-z

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  199 in total

1.  TGF-beta in mammary development and neoplasia.

Authors:  C L Arteaga; H L Moses
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-10       Impact factor: 2.673

Review 2.  Transforming growth factor beta signaling in adult cardiovascular diseases and repair.

Authors:  Thomas Doetschman; Joey V Barnett; Raymond B Runyan; Todd D Camenisch; Ronald L Heimark; Henk L Granzier; Simon J Conway; Mohamad Azhar
Journal:  Cell Tissue Res       Date:  2011-09-28       Impact factor: 5.249

3.  Retinoic acid enhances lactoferrin-induced IgA responses by increasing betaglycan expression.

Authors:  Jeong-Min Lee; Young-Saeng Jang; Bo-Ra Jin; Sun-Jin Kim; Hyeon-Jin Kim; Bo-Eun Kwon; Hyun-Jeong Ko; Sung-Il Yoon; Geun-Shik Lee; Woan-Sub Kim; Goo-Young Seo; Pyeung-Hyeun Kim
Journal:  Cell Mol Immunol       Date:  2015-08-17       Impact factor: 11.530

4.  Betaglycan alters NFκB-TGFβ2 cross talk to reduce survival of human granulosa tumor cells.

Authors:  Maree Bilandzic; Simon Chu; Yao Wang; Han L Tan; Peter J Fuller; Jock K Findlay; Kaye L Stenvers
Journal:  Mol Endocrinol       Date:  2013-01-15

5.  TGFβRIIb mutations trigger aortic aneurysm pathogenesis by altering transforming growth factor β2 signal transduction.

Authors:  Katharine J Bee; David C Wilkes; Richard B Devereux; Craig T Basson; Cathy J Hatcher
Journal:  Circ Cardiovasc Genet       Date:  2012-10-24

6.  Type III TGFβ receptor and Src direct hyaluronan-mediated invasive cell motility.

Authors:  Patrick Allison; Daniella Espiritu; Joey V Barnett; Todd D Camenisch
Journal:  Cell Signal       Date:  2014-12-11       Impact factor: 4.315

7.  Lactoferrin causes IgA and IgG2b isotype switching through betaglycan binding and activation of canonical TGF-β signaling.

Authors:  Y-S Jang; G-Y Seo; J-M Lee; H-Y Seo; H-J Han; S-J Kim; B-R Jin; H-J Kim; S-R Park; K-J Rhee; W-S Kim; P-H Kim
Journal:  Mucosal Immunol       Date:  2014-12-10       Impact factor: 7.313

8.  Binding of insulin-like growth factor (IGF)-binding protein-5 to smooth-muscle cell extracellular matrix is a major determinant of the cellular response to IGF-I.

Authors:  A Parker; C Rees; J Clarke; W H Busby; D R Clemmons
Journal:  Mol Biol Cell       Date:  1998-09       Impact factor: 4.138

9.  Genetic screens to identify elements of the decapentaplegic signaling pathway in Drosophila.

Authors:  L A Raftery; V Twombly; K Wharton; W M Gelbart
Journal:  Genetics       Date:  1995-01       Impact factor: 4.562

Review 10.  Academy of Breastfeeding Medicine founder's lecture 2008: breastfeeding--an extrauterine link between mother and child.

Authors:  Samuli Rautava; W Allan Walker
Journal:  Breastfeed Med       Date:  2009-03       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.